Evidence map›Paper›PMID 25832477›Full record

ArticleInflammation2015

Reduced Expression of miR-23a Suppresses A20 in TLR-stimulated Macrophages.

Ping Peng, Zhiyi Li, Xinyan Liu

Abstract read
PubMed Publisher
In one paragraph

Article in Inflammation, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 19 papers.

0numbers the graph read from it
0cells of the map it votes in
19citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

19 citing papers in PubMed.

  1. Article
  2. Article
  3. Review
  4. Review
  5. Review
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Chlorogenic Acid Promotes Autophagy and AlleviatesFrontiers in cell and developmental biology · 2020
    Article
  12. Cancer immunology research · 2019
    Article
  13. Value of Serum miR-23a, miR-30d, and miR-146a Biomarkers in ST-Elevation Myocardial Infarction.Medical science monitor : international medical journal of experimental and clinical research · 2019
    Article
  14. Article
  15. Article
  16. Article
  17. Mir-23a inhibition attenuates ischemic/reperfusion-induced myocardial apoptosis by targeting XIAP.International journal of clinical and experimental pathology · 2017
    Article
  18. Article
  19. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Ping PengDepartment of Obstetrics and Gynecology, Peking Union Medical College Hospital, Chinese Academy of Medical Science, No. 1, ShaiFuYuan, Dongcheng District, Beijing, China, 100730.
Zhiyi Li
Xinyan Liu

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

High levels of miR-23a expression in human primary macrophages suggested that miR-23a might have an important role in innate immune cells. Therefore, we investigated whether miR-23a regulates the secretion of cytokines by immune cells. Herein, we demonstrate that the expression of miR-23a was reduced in toll-like receptor (TLR)-stimulated macrophages. By targeting A20, miR-23a could affect NF-κB activity and the expression of downstream NF-κB-target genes that encode proinflammatory mediators, such as IL-6 and TNF-α. In summary, our study describes a novel role for miR-23a in the regulation of inflammatory cytokine production in macrophages, which could yield new insights into the regulatory role of miRNAs in the inflammatory response.

Indexed as

AnimalsCell LineCysteine EndopeptidasesGene Expression RegulationInflammation MediatorsIntracellular Signaling Peptides and ProteinsMacrophagesMiceMice, Inbred C57BLMicroRNAsToll-Like ReceptorsTumor Necrosis Factor alpha-Induced Protein 3Cysteine EndopeptidasesInflammation MediatorsIntracellular Signaling Peptides and ProteinsMicroRNAsMirn23b microRNA, mouseTnfaip3 protein, mouseToll-Like ReceptorsTumor Necrosis Factor alpha-Induced Protein 3

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.